US-based Sciton has unveiled its hybrid fractional laser (HFL), diVa, for vaginal tissue rejuvenation.
Vaginal health can be affected during childbirth due to excessive stretching of the tissue and the menopause, which causes dryness, thinning and expose the vaginal walls. Sex can also cause damage.
Sciton’s diVa offers a solution that can be customised, such as separate procedures for pre-menopause and woman who has reached menopause.
diVa investigator Johnny Peet said: "With the addition of diVa, we have a new solution to improve self-esteem and quality of life for our patients.
"So many of our patients can benefit from this type of treatment. I am addressing intimate issues such as painful intercourse or dryness with a real solution.
"They are now coming forward, being treated and are ecstatic about the results."
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
diVa is based on Sciton’s Halo dual fractionated laser technology, which enables the device to generate both ablative and non-ablative wavelengths to the same microscopic treatment zone paving the way for customisable procedures.
The first generated laser causes a deep resurface of the vaginal wall layers, resulting in its replacement with new, healthy tissue.
The second laser heats layers of the tissue, resulting in an inflammatory response to foster healthy cellular activity in the skin.
It involves an automated process where physicians use high-precision automation (HPA) technology to insert the strengthened quartz dilator of the device and press the foot switch.
Treatment involving diVa is suggested to be administered three times with a gap of 30 days, coupled with one annual treatment to maintain results.
Users are advised to avoid intercourse for up to 48 hours.